MedPath

江苏贝佳制药有限公司

Ownership
-
Established
2016-12-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Ambroxol Hydrochloride  Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20244741
Approval Date
Aug 27, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20234255
Approval Date
Sep 28, 2023
NMPA

Chloramphenicol Capsules

Product Name
氯霉素胶囊
Approval Number
国药准字H32026598
Approval Date
Jul 9, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20045746
Approval Date
Jul 9, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20045304
Approval Date
Jul 9, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.